Organization Overview
Historical Acquisition Tree
Alternative names
Key: Quotient (144) Acquired (11)
2,3-butanedione monoxime (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
allopurinol (zyloprim) (1 trial)
belumosudil (Rezurock) (4 trials)
bempedoic acid (NEXLETOL) (1 trial)
berotralstat (Orladeyo) (3 trials)
budesonide (rhinocort) (2 trials)
carbidopa (sinemet) (2 trials)
darolutamide (Nubeqa) (1 trial)
dihydroergotamine (D.H.E. 45) (2 trials)
dolutegravir (tivicay) (1 trial)
drospirenone (Yasmin) (1 trial)
esomeprazole (nexium) (1 trial)
estetrol (NEXTSTELLIS) (2 trials)
ethinyl estradiol (Estinyl) (1 trial)
fluticasone (cutivate) (1 trial)
formoterol (foradil) (2 trials)
glimepiride (amaryl) (1 trial)
Hydroxymethylfurfural (1 trial)
iloperidone (fanapt) (1 trial)
iron sucrose (venofer) (1 trial)
itraconazole (sporanox) (1 trial)
lansoprazole (prevacid) (1 trial)
levodopa (larodopa) (2 trials)
mifepristone (mifeprex) (1 trial)
moxifloxacin (avelox) (1 trial)
nafamostat (ronastat) (1 trial)
olanzapine (zyprexa) (1 trial)
omeprazole (prilosec) (1 trial)
osimertinib (tagrisso) (2 trials)
oxycodone (oxycontin) (1 trial)
pasireotide (signifor) (1 trial)
pentoxifylline (trental) (1 trial)
polyribocytidylic acid (1 trial)
polyriboinosinic acid (1 trial)
prednisone (meticorten) (4 trials)
rabeprazole (pariet) (2 trials)
ranolazine (ranexa) (2 trials)
salmeterol (serevent) (1 trial)
sargramostim (leukine) (1 trial)
selumetinib (Koselugo) (1 trial)
sitagliptin (januvia) (1 trial)
ticagrelor (brilinta) (2 trials)
tiotropium (spiriva) (3 trials)
Aggression (Phase 1)
Alcoholism (Phase 2)
Alzheimer Disease (Phase 1)
Amyotrophic Lateral Sclerosis (Phase 1)
Anemia, Sickle Cell (Phase 1)
Angioedema (Phase 1)
Angioedemas, Hereditary (Phase 1)
Aspergillosis (Phase 1)
Atrial Fibrillation (Phase 1)
Autoimmune Diseases (Phase 1)
Body Weight (Phase 1)
Cardiovascular Diseases (Phase 1)
Communicable Diseases (Phase 1)
Constipation (Phase 2)
Epilepsy (Phase 1)
Eye Diseases (Phase 1)
Filoviridae Infections (Phase 1)
Gonorrhea (Phase 1)
Hemorrhagic Fever, Ebola (Phase 1)
Hyperlipidemias (Phase 1)
Impulsive Behavior (Phase 1)
Infections (Phase 1)
Irritable Bowel Syndrome (Phase 2)
Leishmaniasis (Phase 1)
Leishmaniasis, Cutaneous (Phase 1)
Leishmaniasis, Visceral (Phase 1)
Lung Diseases (Phase 1)
Lung Diseases, Obstructive (Phase 2)
Malaria (Phase 1)
Migraine Disorders (Phase 1)
Migraine with Aura (Phase 1)
Migraine without Aura (Phase 1)
Motor Neuron Disease (Phase 1)
Multiple Sclerosis (Phase 1)
Multiple Sclerosis, Relapsing-Remitting (Phase 1)
Neoplasms (Phase 1)
Nocturia (Phase 1)
Ocular Hypertension (Phase 1)
Parkinson Disease (Phase 1)
Psoriasis (Phase 1)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Respiratory Syncytial Virus Infections (Phase 1)
Respiratory Tract Infections (Phase 1)
Schizophrenia (Phase 1)
Syndrome (Phase 2)
Trypanosomiasis (Phase 1)
Trypanosomiasis, African (Phase 1)
Virus Diseases (Phase 1)
Weight Gain (Phase 1)